Investors
A versatile diagnostic platform with strong licensing potential and attractive margins.
Aligned with global priorities in public health, healthy longevity, and precision medicine.
Established R&D and manufacturing capabilities support efficient global expansion.
Positioned to capitalize on global demand for advanced HIV diagnostics
Innovative diagnostics designed to strengthen public health and improve outcomes.
Join a biotechnology team committed to scientific excellence and sustainable growth.
Our leadership team combines expertise in molecular biology, clinical medicine, data science, and industry operations, with deep experience spanning research, commercialization, and clinical implementation. We are committed to open collaboration and long-term scientific advancement.
Founder & CSO
CEO
Chief Advisor
SVP
VP
Board Secretary
CTO
AVP
R&D Director
Building the Foundation of Precision Medicine
High-sensitivity quantitative detection powered by proprietary intellectual property and advanced data capabilities. Our technology creates meaningful barriers to entry while enabling scalable precision diagnostics.
Supbio is focused on the rapidly growing precision medicine sector, supported by strong and sustained global demand for advanced diagnostic technologies.
Supbio has established a clear business model integrating products, testing services, and technology licensing. This diversified structure supports multiple revenue streams and long-term growth.
Supbio has translated its core technologies into commercialized products and validated services. The team combines scientific expertise with practical experience in product development and market execution.
Supbio’s platform architecture supports expansion into additional applications, disease areas, and international markets. This approach enables efficient growth and long-term strategic flexibility.
We are entering a phase of rapid growth and welcome long-term partners with strategic vision to collaborate in:
